BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22846349)

  • 1. Molecular analysis of centrifugation supernatant fluid from pancreaticobiliary duct samples can improve cancer detection.
    Finkelstein SD; Bibbo M; Loren DE; Siddiqui AA; Solomides C; Kowalski TE; Ellsworth E
    Acta Cytol; 2012; 56(4):439-47. PubMed ID: 22846349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions.
    Deftereos G; Finkelstein SD; Jackson SA; Ellsworth EM; Krishnamurti U; Liu Y; Silverman JF; Binkert CR; Ujevich BA; Mohanty A
    Mod Pathol; 2014 Apr; 27(4):594-601. PubMed ID: 24051700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
    Khalid A; Pal R; Sasatomi E; Swalsky P; Slivka A; Whitcomb D; Finkelstein S
    Gut; 2004 Dec; 53(12):1860-5. PubMed ID: 15542529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sequential mutation accumulation in pancreas and bile duct brushing cytology.
    Lapkus O; Gologan O; Liu Y; Swalsky PA; Wilson MM; Finkelstein SD; Silverman JF
    Mod Pathol; 2006 Jul; 19(7):907-13. PubMed ID: 16648872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnostic testing as an adjunct to morphologic evaluation of pancreatic ductal system brushings: potential augmentation for diagnostic sensitivity.
    Willmore-Payne C; Volmar KE; Huening MA; Holden JA; Layfield LJ
    Diagn Cytopathol; 2007 Apr; 35(4):218-24. PubMed ID: 17351944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations?
    Krishnamurti U; Sasatomi E; Swalsky PA; Finkelstein SD; Ohori NP
    Arch Pathol Lab Med; 2007 Jan; 131(1):74-80. PubMed ID: 17227126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center.
    Malhotra N; Jackson SA; Freed LL; Styn MA; Sidawy MK; Haddad NG; Finkelstein SD
    BMC Gastroenterol; 2014 Aug; 14():135. PubMed ID: 25084836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
    Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
    Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.
    Kipp BR; Fritcher EG; Clayton AC; Gores GJ; Roberts LR; Zhang J; Levy MJ; Halling KC
    J Mol Diagn; 2010 Nov; 12(6):780-6. PubMed ID: 20864634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of touch imprint cytology as a simple method to enrich tumor cells for molecular analysis.
    Dogan S; Becker JC; Rekhtman N; Tang LH; Nafa K; Ladanyi M; Klimstra DS
    Cancer Cytopathol; 2013 Jul; 121(7):354-60. PubMed ID: 23576371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy.
    Dudley JC; Zheng Z; McDonald T; Le LP; Dias-Santagata D; Borger D; Batten J; Vernovsky K; Sweeney B; Arpin RN; Brugge WR; Forcione DG; Pitman MB; Iafrate AJ
    J Mol Diagn; 2016 Jan; 18(1):124-30. PubMed ID: 26596524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.
    Fasanella KE; Krasinskas A; Schoedel KE; Sasatomi E; Slivka A; Whitcomb DC; Sanders M; Nodit L; Raab S; McGrath KM; Ohori NP; Khalid A
    Pancreatology; 2010; 10(4):429-33. PubMed ID: 20720444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions.
    Finkelstein SD; Bibbo M; Kowalski TE; Loren DE; Siddiqui AA; Solomides C; Ellsworth E
    Diagn Cytopathol; 2014 Aug; 42(8):719-25. PubMed ID: 24265269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases.
    Van Laethem JL; Bourgeois V; Parma J; Delhaye M; Cochaux P; Velu T; Devière J; Cremer M
    Gastrointest Endosc; 1998 Jun; 47(6):479-85. PubMed ID: 9647372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brush cytology of ductal strictures during ERCP.
    Macken E; Drijkoningen M; Van Aken E; Van Steenbergen W
    Acta Gastroenterol Belg; 2000; 63(3):254-9. PubMed ID: 11189981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10-year retrospective review.
    Sun T; Zuo T; Hui P; Cai G
    Cancer Cytopathol; 2022 Jul; 130(7):558-565. PubMed ID: 35417072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures.
    Ryan ME; Baldauf MC
    Gastrointest Endosc; 1994; 40(2 Pt 1):133-9. PubMed ID: 8013809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.